An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific ...

Amber Salzman, Ph.D., CEO at Epicrispr Biotechnologies, joined the Business of Biotech live in Boston to talk about ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to ...

DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...

Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

MIT’s CRISPR sensor detects cancer and HIV for 50 cents and stays effective for two months without refrigeration.

MIT has developed a DNA sensor that can detect HPV and HIV infections through voltage changes. The sensor is durable and ...